Prenetics Global Limited Announces Proposed Public Offering
Prenetics Global (NASDAQ:PRE) announced on Oct 25, 2025 that it has commenced a public offering of Class A ordinary shares (or prefunded warrants) and common warrants (the "Offering").
The company said net proceeds are intended to fund the global expansion of IM8 and the strategic accumulation of Bitcoin (BTC) as part of a dual health-and-wealth strategy. The Offering is being made from an effective Form F-3 shelf registration declared effective by the SEC on Sept 11, 2025, and is subject to market conditions with no assurance as to completion, size, or terms.
Dominari Securities is acting as sole placement agent; a preliminary prospectus supplement and shelf prospectus will be filed with the SEC and made available to investors.
Prenetics Global (NASDAQ:PRE) ha annunciato il 25 ottobre 2025 che ha avviato un'offerta pubblica di azioni ordinarie di Classe A (o warrant prefiniti) e warrant comuni (la Offerta).
La società ha dichiarato che i proventi netti sono destinati a finanziare l'espansione globale di IM8 e l'accumulazione strategica di Bitcoin (BTC) come parte di una strategia duale salute-e-ricchezza. L'Offerta è effettuata tramite una registrazione su scaffale Form F-3 efficace dichiarata efficace dalla SEC il 11 settembre 2025, ed è soggetta alle condizioni di mercato senza alcuna garanzia di completamento, dimensione o termini.
Dominari Securities agisce come unico agente di collocamento; un supplemento di prospetto preliminare e un prospetto di scaffale saranno depositati presso la SEC e messi a disposizione degli investitori.
Prenetics Global (NASDAQ:PRE) anunció el 25 de octubre de 2025 que ha iniciado una oferta pública de acciones ordinarias clase A (o warrants prefinanciados) y warrants comunes (la Oferta).
La compañía dijo que los fondos netos se destinarán a financiar la expansión global de IM8 y la acumulación estratégica de Bitcoin (BTC) como parte de una estrategia dual de salud y riqueza. La Oferta se realiza a partir de un registro de estante Form F-3 vigente, declarado efectivo por la SEC el 11 de septiembre de 2025, y está sujeta a condiciones de mercado sin garantía de finalización, tamaño o términos.
Dominari Securities actúa como único agente de colocación; se presentará ante la SEC un suplemento de prospecto preliminar y un prospecto de estante y estará disponible para los inversores.
Prenetics Global (NASDAQ:PRE)가 2025년 10월 25일 공모를 시작했다고 발표했습니다. 이는 클래스 A 일반주식(또는 선납 워런트)과 일반 워런트를 대상으로 합니다.
회사는 순자금이 IM8의 글로벌 확장과 비트코인(BTC)의 전략적 축적에 사용되어 건강과 부를 함께 추구하는 이중 전략의 일환이 될 것이라고 밝혔습니다. 공모는 미국 증권거래위원회(SEC)가 2025년 9월 11일에 효력이 발생한 Form F-3 셀프 레지스트레이션의 효과를 바탕으로 이루어지며, 시장 상황에 따라 완료, 규모 또는 조건에 대한 보장이 없습니다.
Dominari Securities가 단독 배정 에이전트로 활동합니다. 예비prospectus 보충서와 셀프 프로스펙트루스가 SEC에 제출되어 투자자들에게 제공될 예정입니다.
Prenetics Global (NASDAQ:PRE) a annoncé le 25 octobre 2025 qu'elle avait commencé une offre publique d'actions ordinaires de Classe A (ou warrants préfinancés) et de warrants ordinaires (ce qu'on appelle l Offre).
La société a indiqué que les produits nets seront destinés à financer l'expansion mondiale de IM8 et l'accumulation stratégique de Bitcoin (BTC) dans le cadre d'une stratégie double santé et richesse. L'Offre est effectuée à partir d'un enregistrement d'étagère Form F-3, déclaré efficace par la SEC le 11 septembre 2025, et est soumise aux conditions de marché sans garantie quant à l'achèvement, à la taille ou aux termes.
Dominari Securities agit en tant que seul agent de placement; un supplément de prospectus préliminaire et un prospectus d'étagère seront déposés auprès de la SEC et mis à la disposition des investisseurs.
Prenetics Global (NASDAQ:PRE) gab am 25. Oktober 2025 bekannt, dass sie eine öffentliche Ausgabe von Class-A-Ordentlichen (oder vorfinanzierte Warrants) und gewöhnlichen Warrants gestartet hat.
Das Unternehmen erklärte, dass der Nettogewinn dazu bestimmt ist, die globale Expansion von IM8 und die strategische Ansammlung von Bitcoin (BTC) als Teil einer Dual-Health-and-Wealth-Strategie zu finanzieren. Das Angebot erfolgt auf Basis einer wirksamen Form F-3-Shelf-Registrierung, die von der SEC am 11. September 2025 für wirksam erklärt wurde, und es unterliegt Marktkonditionen, ohne Garantie für Abschluss, Größe oder Bedingungen.
Dominari Securities fungiert als alleiniger Platzierungsagent; ein vorläufiger Prospektzusatz und ein Shelf-Prospekt werden bei der SEC eingereicht und Investoren zur Verfügung gestellt.
Prenetics Global (NASDAQ:PRE) أعلنت في 25 أكتوبر 2025 أنها بدأت عرضاً عاماً لأسهم عادية من الفئة A (أو مراكز خيارات مقدمة التمويل) وذمم warrants مشتركة (المعروفة بـ العرض).
قالت الشركة إن العوائد الصافية ستستخدم لتمويل التوسع العالمي لـ IM8 والتجميع الاستراتيجي لـ Bitcoin (BTC) كجزء من استراتيجية مزدوجة للصحة والثروة. يعقد العرض بناءً على سجل رف Shelf Form F-3 الذي أعلته SEC كفعال في 11 سبتمبر 2025، وهو خاضع لظروف السوق دون ضمان للإتمام أو الحجم أو الشروط.
Dominari Securities تعمل كوكيل ترتيب وحيد؛ سيتم تقديم ملحق نشرة أولية ونشرة رف Shelf إلى SEC وتكون متاحة للمستثمرين.
- Proceeds targeted to IM8 global expansion
- Company pursuing a dual health and wealth strategy including Bitcoin accumulation
- Form F-3 shelf registration declared effective on Sept 11, 2025
- Offering is subject to market conditions with no assurance of completion
- Actual size and terms of the Offering are not yet determined
Insights
Prenetics launched a registered public offering to fund IM8 expansion and accumulate Bitcoin; terms and size are pending.
Prenetics plans a public offering of Class A Ordinary Shares (or prefunded warrants) and common warrants under an effective Form F-3 shelf (No. 333-288824) declared effective on
The announcement is informative but incomplete: the Offering is explicitly subject to market conditions and the Company gives no final size, price, or timeline, so the immediate economic effect is uncertain and the outcome depends on terms filed in the preliminary and final prospectus supplements. Key risks stated in the release include the possibility the Offering may not complete and that material terms remain undecided; the financing could be dilutive if equity is issued. Watch for the filed preliminary prospectus supplement on the SEC website and the final prospectus supplement for concrete size, price, and use‑of‑proceeds details; these filings will resolve near‑term execution questions within the coming weeks once the supplements are posted.
CHARLOTTE, N.C., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (“Prenetics” or the “Company”), a leading health sciences company, today announced that it has commenced a public offering of shares of its Class A Ordinary Shares (or prefunded warrants in lieu thereof) and common warrants (the “Offering”). The Company will allocate proceeds from the offering toward the global expansion of IM8, driven by its explosive growth, and the strategic accumulation of Bitcoin (BTC) as part of its pioneering dual-pronged health and wealth strategy.
The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
Dominari Securities LLC is acting as the sole placement agent for the Offering
This Offering is being made pursuant to an effective shelf registration statement on Form F-3, as amended (No. 333-288824), declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on September 11, 2025. A preliminary prospectus supplement and accompanying shelf prospectus (“Shelf Prospectus”) describing the terms of the Offering will be filed with the SEC and will be available on the SEC’s website located at https://www.sec.gov. Electronic copies of the preliminary prospectus supplement (together with the final prospectus supplement for this Offering, the “Prospectus Supplement”) and the accompanying shelf prospectus may be obtained, when available, by contacting Dominari Securities LLC, Attention: Syndicate Department, 725 5th Ave 23 Floor, New York, NY 10022, by email at info@dominarisecurities.com, or by telephone at (212) 393-4500.
Before investing in this Offering, interested parties should read, in their entirety, the prospectus supplement and the Shelf Prospectus and the other documents that the Company has filed with the SEC pertaining to the Offering and that are incorporated by reference in the Prospectus Supplement and the Shelf Prospectus, which provide more information about the Company and such Offering.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Prenetics
Prenetics (NASDAQ: PRE) is a leading health sciences company redefining the future of health and longevity through IM8, its flagship consumer brand co-founded with David Beckham and now one of the world’s fastest-growing supplement brands.
As the first consumer health company to establish a Bitcoin Treasury, Prenetics continues to pioneer at the intersection of health innovation and digital assets — purchasing 1 Bitcoin per day, now totaling 272 BTC as of October 24, 2025.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar statements. Prenetics may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Prenetics’ beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s ability to complete the offering, the Company’s ability to execute its new Bitcoin treasury strategy; the volatility of Bitcoin; the Company’s ability to manage its growth and expansion; the Company’s ability to compete in the highly competitive consumer health market; and other risks and uncertainties. Further information regarding these and other risks is included in Prenetics’ filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Prenetics does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us
Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com
FAQ
What did Prenetics (PRE) announce on Oct 25, 2025 about a public offering?
How will Prenetics (PRE) use proceeds from the Oct 2025 offering?
Is the Prenetics (PRE) offering guaranteed to close and what are the terms?
Where can investors find the Prenetics (PRE) prospectus for the Oct 2025 offering?
Who is the placement agent for Prenetics (PRE) Oct 2025 offering?
